Adc Therapeutics SA (ADCT): A Case For Going Higher

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

This NYSE-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $3.65 and fluctuated between $3.8180 as its day high and $3.4500 as its day low. The current market capitalization of Adc Therapeutics SA is $294.34M. A total of 0.52 million shares were traded on the day, compared to an average of 826.98K shares.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ADCT has a high of $5.05 and a low of $0.36.

As of this writing, ADCT has an earnings estimate of $Agree Realty Corporation per share for the current quarter. EPS was calculated based on a consensus of AdvisorShares Vice ETF estimates, with a high estimate of $Arcturus Therapeutics Holdings per share and a lower estimate of $ADC Therapeutics SA.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ADCT’s latest balance sheet shows that the firm has $466.54M in Cash & Short Term Investments as of fiscal 2021. There were $139.70M in debt and $73.94M in liabilities at the time. Its Book Value Per Share was -$0.67, while its Total Shareholder’s Equity was $166.09M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ADCT is Buy with a score of 4.00.

Most Popular

Related Posts